These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35214000)

  • 1. Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery.
    Rodríguez DA; Vader P
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
    Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
    Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology.
    Martin Perez C; Conceição M; Raz R; Wood MJA; Roberts TC
    Methods Mol Biol; 2022; 2383():119-141. PubMed ID: 34766286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging as a tool to accelerate the translation of extracellular vesicle-based therapies for central nervous system diseases.
    Gao Y; Chu C; Jablonska A; Bulte JWM; Walczak P; Janowski M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1688. PubMed ID: 33336512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine.
    Rosso G; Cauda V
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinspired extracellular vesicle-coated silica nanoparticles as selective delivery systems.
    Dumontel B; Jiménez-Jiménez C; Vallet-Regí M; Manzano M
    Mater Today Bio; 2023 Dec; 23():100850. PubMed ID: 38024844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle-based drug delivery systems for cancer treatment.
    Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
    Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Obstacles to Current Extracellular Vesicle-Mediated Drug Delivery Research.
    Lee H; Zhang D; Rai A; Jin Y
    J Pharm Pharm; 2017; 4(2):156-158. PubMed ID: 29355245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles as drug delivery systems: lessons from the liposome field.
    van der Meel R; Fens MH; Vader P; van Solinge WW; Eniola-Adefeso O; Schiffelers RM
    J Control Release; 2014 Dec; 195():72-85. PubMed ID: 25094032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.
    Sharma S; Masud MK; Kaneti YV; Rewatkar P; Koradia A; Hossain MSA; Yamauchi Y; Popat A; Salomon C
    Small; 2021 Oct; 17(42):e2102220. PubMed ID: 34216426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
    Kooijmans SAA; de Jong OG; Schiffelers RM
    Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of extracellular vesicles as drug delivery vehicles.
    Kim SM; Kim HS
    Stem Cell Investig; 2017; 4():74. PubMed ID: 29057246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles: powerful candidates in nano-drug delivery systems.
    Liu X; Cao Y; Wang S; Liu J; Hao H
    Drug Deliv Transl Res; 2024 Feb; 14(2):295-311. PubMed ID: 37581742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.